|

Mid-day market update: Nasdaq dips over 400 points, Marvell Technology shares rise following upbeat earnings

Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 49,716,820 cases with around 806,390 deaths. India confirmed a total of at least 34,615,750 cases and 470,110 deaths, while Brazil reported over 22,118,780 COVID-19 cases with 615,220 deaths. In total, there were at least 264,609,610 cases of COVID-19 worldwide with more than 5,253,110 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares climbed 0.8% on Friday. Meanwhile, top gainers in the sector included Tyson Foods, Inc. TSN +2.17% (Get Free Alerts for TSN), up 3% and Sendas Distribuidora S.A. ASAI +5.68% (Get Free Alerts for ASAI) up 6%.

In trading on Friday, information technology shares fell 2%.

Top Headline

Big Lots, Inc. BIG +4.25% reported better-than-expected earnings for its third quarter, but issued weak earnings guidance for FY21.

Big Lots reported a quarterly loss of $0.14 per share, beating analysts’ estimates of a loss of $0.16 per share. The company’s quarterly sales came in at $1.34 billion, versus expectations of $1.32 billion.

Big Lots said it sees Q4 EPS of $2.05-$2.20 per share, versus analysts’ estimates of $2.39 per share. The company also projects FY21 EPS of $5.70-$5.85 per share, versus expectations of $5.97 per share. The company also reported a $250 million buyback plan.

Equities Trading UP

Celyad Oncology SA CYAD +40.45% shares shot up 40% to $5.11. Celyad Oncology announced a private placement worth $32.5 million (about €28.7 million) with Fortress Investment Group. The offering includes the private placement of 6.5 million shares and will close by December 8.

Shares of Marvell Technology, Inc. MRVL +17.68% got a boost, shooting 17% to $83.10 after the company reported better-than-expected Q3 results and issued Q4 guidance above estimates. Goldman Sachs and Cowen & Co. upgraded the stock.

Longeveron Inc. LGVN +34.89% shares were also up, gaining 30% to $23.31. The FDA granted Orphan Drug designation to Longeveron’s lead investigational product Lomecel-B for Hypoplastic left heart syndrome (HLHS).

Equities Trading DOWN

Asana, Inc. ASAN -27% shares tumbled 27% to $66.16 after the company reported Q3 earnings and issued guidance.

Shares of DocuSign, Inc. DOCU -40.52% were down 41% to $138.02 after the company issued Q4 2021 and FY22 revenue guidance below estimates. Several analysts also downgraded the stock.

Esperion Therapeutics, Inc. ESPR -40.19% was down, falling 41% to $5.30. Esperion Therapeutics priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14 million shares at $7/share and accompanying warrant.

Commodities

In commodity news, oil traded up 2.7% to $68.28, while gold traded up 0.5% to $1,772.10.

Silver traded down 0.6% Friday to $22.185 while copper fell 0.5% to $4.2790.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.59%, the Spanish Ibex Index fell 0.78% and the German DAX 30 dropped 0.70%. Meanwhile, the London’s FTSE 100 fell 0.11%, French CAC 40 slipped 0.56% and Italy’s FTSE MIB fell 0.37%.

The IHS Markit Eurozone services PMI was revised lower to 55.9 in November versus a preliminary reading of 56.6. The IHS Markit France services PMI climbed to 57.4 in November from 56.6 in the prior month, while industrial production increased 0.9% in October. France's government budget deficit increased to EUR 171.6 billion in January-October of 2021, compared to EUR 159.9 billion in the year-ago period.

German services PMI was fell to 52.7 in November from a preliminary estimates of 53.4. Spain’s services PMI climbed to 59.8 in November from 56.6 a month ago, while Italy’s services PMI increased to 55.9 in November from 52.4 in the prior month.

Economics

The US economy added only 210,000 jobs in November, while unemployment rate dropped by 0.4 percentage points to 4.2% in November.

The IHS Markit services PMI was revised higher to 58.0 in November versus a preliminary reading of 57.0.

US factory orders rose 1% month-over-month in October.

The ISM non-manufacturing PMI rose to 69.1 in November from 66.7 in the prior month.

The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.